A 0 1 0 1 O
family 2 8 2 8 O
history 9 16 9 16 O
of 17 19 17 19 O
HBOC 20 24 20 24 B-cancer
is 25 27 25 27 O
defined 28 35 28 35 O
by 36 38 36 38 O
NCCN 39 43 39 43 O
Genetic 44 51 44 51 O
/ 51 52 51 52 O
Familial 52 60 52 60 O
High 61 65 61 65 O
- 65 66 65 66 O
Risk 66 70 66 70 O
Assessment 71 81 71 81 O
: 81 82 81 82 O
Breast 83 89 83 89 O
and 90 93 90 93 O
Ovarian 94 101 94 101 O
guideline 102 111 102 111 O

AST(SGOT)/ALT(SGPT 0 18 112 130 B-clinical_variable
) 18 19 130 131 I-clinical_variable
less 20 24 132 136 O
than 25 29 137 141 O
or 30 32 142 144 O
equal 33 38 145 150 O
to 39 41 151 153 O
3 42 43 154 155 B-upper_bound
X 44 45 156 157 I-upper_bound
institutional 46 59 158 171 I-upper_bound
upper 60 65 172 177 I-upper_bound
limit 66 71 178 183 I-upper_bound
of 72 74 184 186 I-upper_bound
normal 75 81 187 193 I-upper_bound

Age 0 3 194 197 B-age
greater 4 11 198 205 O
than 12 16 206 210 O
or 17 19 211 213 O
equal 20 25 214 219 O
to 26 28 220 222 O
18 29 31 223 225 B-lower_bound
years 32 37 226 231 I-lower_bound

All 0 3 232 235 O
patients 4 12 236 244 O
except 13 19 245 251 O
Cohort 20 26 252 258 O
6 27 28 259 260 O
must 29 33 261 265 O
have 34 38 266 270 O
at 39 41 271 273 O
least 42 47 274 279 O
one 48 51 280 283 B-lower_bound
lesion 52 58 284 290 O
deemed 59 65 291 297 O
safe 66 70 298 302 O
to 71 73 303 305 O
biopsy 74 80 306 312 B-treatment
and 81 84 313 316 O
be 85 87 317 319 O
willing 88 95 320 327 O
to 96 98 328 330 O
undergo 99 106 331 338 O
a 107 108 339 340 O
mandatory 109 118 341 350 O
baseline 119 127 351 359 O
biopsy 128 134 360 366 O

All 0 3 367 370 O
patients 4 12 371 379 O
must 13 17 380 384 O
have 18 22 385 389 O
measurable 23 33 390 400 O
disease 34 41 401 408 O
, 41 42 408 409 O
defined 43 50 410 417 O
as 51 53 418 420 O
at 54 56 421 423 O
least 57 62 424 429 O
one 63 66 430 433 B-lower_bound
lesion 67 73 434 440 O
that 74 78 441 445 O
can 79 82 446 449 O
be 83 85 450 452 O
accurately 86 96 453 463 O
measured 97 105 464 472 O
in 106 108 473 475 O
at 109 111 476 478 O
least 112 117 479 484 O
one 118 121 485 488 O
dimension 122 131 489 498 O
( 132 133 499 500 O
longest 133 140 500 507 O
diameter 141 149 508 516 O
to 150 152 517 519 O
be 153 155 520 522 O
recorded 156 164 523 531 O
for 165 168 532 535 O
non 169 172 536 539 O
- 172 173 539 540 O
nodal 173 178 540 545 O
lesions 179 186 546 553 O
and 187 190 554 557 O
short 191 196 558 563 O
axis 197 201 564 568 O
for 202 205 569 572 O
nodal 206 211 573 578 O
lesions 212 219 579 586 O
) 219 220 586 587 O
as 221 223 588 590 O
greater 224 231 591 598 O
than 232 236 599 603 O
or 237 239 604 606 O
equal 240 245 607 612 O
to 246 248 613 615 O
20 249 251 616 618 B-lower_bound
mm 252 254 619 621 I-lower_bound
with 255 259 622 626 O
conventional 260 272 627 639 B-treatment
techniques 273 283 640 650 I-treatment
or 284 286 651 653 O
as 287 289 654 656 O
greater 290 297 657 664 O
than 298 302 665 669 O
or 303 305 670 672 O
equal 306 311 673 678 O
to 312 314 679 681 O
10 315 317 682 684 B-lower_bound
mm 318 320 685 687 I-lower_bound
with 321 325 688 692 O
spiral 326 332 693 699 B-treatment
CT 333 335 700 702 I-treatment
scan 336 340 703 707 I-treatment

All 0 3 708 711 O
subjects 4 12 712 720 O
of 13 15 721 723 O
reproductive 16 28 724 736 O
potential 29 38 737 746 O
must 39 43 747 751 O
also 44 48 752 756 O
agree 49 54 757 762 B-contraception_consent
to 55 57 763 765 I-contraception_consent
use 58 61 766 769 I-contraception_consent
both 62 66 770 774 I-contraception_consent
a 67 68 775 776 I-contraception_consent
barrier 69 76 777 784 I-contraception_consent
method 77 83 785 791 I-contraception_consent
and 84 87 792 795 I-contraception_consent
a 88 89 796 797 I-contraception_consent
second 90 96 798 804 I-contraception_consent
method 97 103 805 811 I-contraception_consent
of 104 106 812 814 I-contraception_consent
birth 107 112 815 820 I-contraception_consent
control 113 120 821 828 I-contraception_consent
during 121 127 829 835 O
the 128 131 836 839 O
course 132 138 840 846 O
of 139 141 847 849 O
the 142 145 850 853 O
study 146 151 854 859 O
and 152 155 860 863 O
for 156 159 864 867 O
four 160 164 868 872 B-upper_bound
months 165 171 873 879 I-upper_bound
after 172 177 880 885 I-upper_bound
the 178 181 886 889 O
last 182 186 890 894 O
dose 187 191 895 899 O
of 192 194 900 902 O
study 195 200 903 908 B-treatment
drug(s 201 207 909 915 I-treatment
) 207 208 915 916 I-treatment

Another 0 7 917 924 O
previous 8 16 925 933 O
or 17 19 934 936 O
current 20 27 937 944 O
invasive 28 36 945 953 O
malignancy 37 47 954 964 B-cancer
within 48 54 965 971 O
the 55 58 972 975 O
last 59 63 976 980 B-upper_bound
2 64 65 981 982 I-upper_bound
years 66 71 983 988 I-upper_bound
, 71 72 988 989 O
with 73 77 990 994 O
the 78 81 995 998 O
exception 82 91 999 1008 O
of 92 94 1009 1011 O
curatively 95 105 1012 1022 O
treated 106 113 1023 1030 O
stage 114 119 1031 1036 B-cancer
Ia 120 122 1037 1039 I-cancer
cervical 123 131 1040 1048 I-cancer
carcinoma 132 141 1049 1058 I-cancer
, 141 142 1058 1059 O
or 143 145 1060 1062 O
resected 146 154 1063 1071 O
stage 155 160 1072 1077 B-cancer
Ia 161 163 1078 1080 I-cancer
endometrial 164 175 1081 1092 I-cancer
cancer 176 182 1093 1099 I-cancer
, 182 183 1099 1100 O
and 184 187 1101 1104 O
noninvasive 188 199 1105 1116 B-cancer
nonmelanoma 200 211 1117 1128 I-cancer
skin 212 216 1129 1133 I-cancer
cancers 217 224 1134 1141 I-cancer

ECOG 0 4 1142 1146 B-clinical_variable
performance 5 16 1147 1158 I-clinical_variable
status 17 23 1159 1165 I-clinical_variable
less 24 28 1166 1170 O
than 29 33 1171 1175 O
or 34 36 1176 1178 O
equal 37 42 1179 1184 O
to 43 45 1185 1187 O
2 46 47 1188 1189 B-upper_bound

ER 0 2 1190 1192 B-clinical_variable
/ 2 3 1192 1193 O
PR 3 5 1193 1195 B-clinical_variable
/ 5 6 1195 1196 O
HER2 6 10 1196 1200 B-clinical_variable
status 11 17 1201 1207 O
needs 18 23 1208 1213 O
to 24 26 1214 1216 O
be 27 29 1217 1219 O
documented 30 40 1220 1230 O
either 41 47 1231 1237 O
by 48 50 1238 1240 O
an 51 53 1241 1243 O
outside 54 61 1244 1251 O
source 62 68 1252 1258 O
or 69 71 1259 1261 O
at 72 74 1262 1264 O
NCI 75 78 1265 1268 O

Electrolyte 0 11 1269 1280 O
abnormalities 12 25 1281 1294 O
that 26 30 1295 1299 O
are 31 34 1300 1303 O
corrected 35 44 1304 1313 O
with 45 49 1314 1318 O
supplementation 50 65 1319 1334 B-treatment

For 0 3 1335 1338 O
Cohort 4 10 1339 1345 O
5 11 12 1346 1347 O
, 12 13 1347 1348 O
the 14 17 1349 1352 O
second 18 24 1353 1359 O
biopsy 25 31 1360 1366 B-treatment
at 32 34 1367 1369 O
progression 35 46 1370 1381 O
is 47 49 1382 1384 O
mandatory 50 59 1385 1394 O
for 60 63 1395 1398 O
the 64 67 1399 1402 O
responders 68 78 1403 1413 O
( 79 80 1414 1415 O
PR 80 82 1415 1417 B-clinical_variable
/ 82 83 1417 1418 I-clinical_variable
CR 83 85 1418 1420 I-clinical_variable
/ 85 86 1420 1421 I-clinical_variable
SD 86 88 1421 1423 I-clinical_variable
) 88 89 1423 1424 O
> 90 91 1425 1426 O
4 92 93 1427 1428 B-lower_bound
months 94 100 1429 1435 I-lower_bound

For 0 3 1436 1439 O
Cohorts 4 11 1440 1447 O
1 12 13 1448 1449 O
- 13 14 1449 1450 O
3 14 15 1450 1451 O
, 15 16 1451 1452 O
5 17 18 1453 1454 O
and 19 22 1455 1458 O
6 23 24 1459 1460 O
: 24 25 1460 1461 O
patients 26 34 1462 1470 O
must 35 39 1471 1475 O
have 40 44 1476 1480 O
breast 45 51 1481 1487 B-cancer
and/or 52 58 1488 1494 O
epithelial 59 69 1495 1505 B-cancer
or 70 72 1506 1508 O
endometrioid 73 85 1509 1521 B-cancer
ovarian 86 93 1522 1529 I-cancer
cancer 94 100 1530 1536 I-cancer
, 100 101 1536 1537 O
primary 102 109 1538 1545 B-cancer
peritoneal 110 120 1546 1556 I-cancer
cancer 121 127 1557 1563 I-cancer
, 127 128 1563 1564 O
and/or 129 135 1565 1571 O
fallopian 136 145 1572 1581 B-cancer
tube 146 150 1582 1586 I-cancer
cancer 151 157 1587 1593 I-cancer
histologically 158 172 1594 1608 O
or 173 175 1609 1611 O
cytologically 176 189 1612 1625 O
confirmed 190 199 1626 1635 O
at 200 202 1636 1638 O
the 203 206 1639 1642 O
NCI 207 210 1643 1646 O
that 211 215 1647 1651 O
is 216 218 1652 1654 O
metastatic 219 229 1655 1665 O
or 230 232 1666 1668 O
unresectable 233 245 1669 1681 O
and 246 249 1682 1685 O
for 250 253 1686 1689 O
which 254 259 1690 1695 O
standard 260 268 1696 1704 O
curative 269 277 1705 1713 O
measures 278 286 1714 1722 O
do 287 289 1723 1725 O
not 290 293 1726 1729 O
exist 294 299 1730 1735 O
or 300 302 1736 1738 O
are 303 306 1739 1742 O
no 307 309 1743 1745 O
longer 310 316 1746 1752 O
effective 317 326 1753 1762 O

HIV- 0 4 1763 1767 B-chronic_disease
positive 5 13 1768 1776 O
patients 14 22 1777 1785 O
who 23 26 1786 1789 O
are 27 30 1790 1793 O
not 31 34 1794 1797 O
on 35 37 1798 1800 O
HAART 38 43 1801 1806 B-clinical_variable
and 44 47 1807 1810 O
have 48 52 1811 1815 O
CD4 53 56 1816 1819 B-clinical_variable
counts 57 63 1820 1826 I-clinical_variable
> 64 65 1827 1828 O
500 66 69 1829 1832 B-lower_bound
will 70 74 1833 1837 O
be 75 77 1838 1840 O
considered 78 88 1841 1851 O
on 89 91 1852 1854 O
an 92 94 1855 1857 O
individual 95 105 1858 1868 O
basis 106 111 1869 1874 O

HIV 0 3 1875 1878 B-chronic_disease
- 3 4 1878 1879 O
positive 4 12 1879 1887 O
patients 13 21 1888 1896 O
on 22 24 1897 1899 O
combination 25 36 1900 1911 O
antiretroviral 37 51 1912 1926 B-treatment
therapy 52 59 1927 1934 I-treatment
are 60 63 1935 1938 O
ineligible 64 74 1939 1949 O
because 75 82 1950 1957 O
of 83 85 1958 1960 O
the 86 89 1961 1964 O
potential 90 99 1965 1974 O
for 100 103 1975 1978 O
pharmacokinetic 104 119 1979 1994 O
interactions 120 132 1995 2007 O
with 133 137 2008 2012 O
LY2606368 138 147 2013 2022 O

Lack 0 4 2023 2027 O
of 5 7 2028 2030 O
recovery 8 16 2031 2039 O
of 17 19 2040 2042 O
prior 20 25 2043 2048 O
adverse 26 33 2049 2056 O
events 34 40 2057 2063 O
due 41 44 2064 2067 O
to 45 47 2068 2070 O
prior 48 53 2071 2076 B-treatment
cancer 54 60 2077 2083 I-treatment
therapy 61 68 2084 2091 I-treatment
to 69 71 2092 2094 O
Grade 72 77 2095 2100 B-clinical_variable
less 78 82 2101 2105 O
than 83 87 2106 2110 O
or 88 90 2111 2113 O
equal 91 96 2114 2119 O
to 97 99 2120 2122 O
1 100 101 2123 2124 B-upper_bound
( 102 103 2125 2126 O
NCI 103 106 2126 2129 O
CTCAE 107 112 2130 2135 O
; 112 113 2135 2136 O
except 114 120 2137 2143 O
alopecia 121 129 2144 2152 B-chronic_disease
) 129 130 2152 2153 O

Patients 0 8 2154 2162 O
enrolling 9 18 2163 2172 O
in 19 21 2173 2175 O
Cohort 22 28 2176 2182 O
5 29 30 2183 2184 O
, 30 31 2184 2185 O
the 32 35 2186 2189 O
recurrent 36 45 2190 2199 O
platinum 46 54 2200 2208 O
- 54 55 2208 2209 O
resistant 55 64 2209 2218 O
sporadic 65 73 2219 2227 O
high 74 78 2228 2232 O
grade 79 84 2233 2238 O
serous 85 91 2239 2245 O
epithelial 92 102 2246 2256 O
or 103 105 2257 2259 O
high 106 110 2260 2264 O
grade 111 116 2265 2270 O
endometrioid 117 129 2271 2283 O
ovarian 130 137 2284 2291 B-cancer
cancer 138 144 2292 2298 I-cancer
group 145 150 2299 2304 O
, 150 151 2304 2305 O
must 152 156 2306 2310 O
have 157 161 2311 2315 O
a 162 163 2316 2317 O
negative 164 172 2318 2326 O
family 173 179 2327 2333 O
history 180 187 2334 2341 O
of 188 190 2342 2344 O
HBOC 191 195 2345 2349 B-chronic_disease
syndrome 196 204 2350 2358 I-chronic_disease
, 204 205 2358 2359 O
or 206 208 2360 2362 O
negative 209 217 2363 2371 O
gBRCA1/2 218 226 2372 2380 O
m 226 227 2380 2381 O
test 228 232 2382 2386 O

Patients 0 8 2387 2395 O
enrolling 9 18 2396 2405 O
in 19 21 2406 2408 O
Cohort 22 28 2409 2415 O
6 29 30 2416 2417 O
, 30 31 2417 2418 O
the 32 35 2419 2422 O
recurrent 36 45 2423 2432 O
platinum 46 54 2433 2441 O
- 54 55 2441 2442 O
resistant 55 64 2442 2451 O
sporadic 65 73 2452 2460 O
high 74 78 2461 2465 B-cancer
grade 79 84 2466 2471 I-cancer
serous 85 91 2472 2478 I-cancer
epithelial 92 102 2479 2489 I-cancer
or 103 105 2490 2492 O
high 106 110 2493 2497 B-cancer
grade 111 116 2498 2503 I-cancer
endometrioid 117 129 2504 2516 I-cancer
ovarian 130 137 2517 2524 I-cancer
cancer 138 144 2525 2531 I-cancer
group 145 150 2532 2537 O
, 150 151 2537 2538 O
must 152 156 2539 2543 O
have 157 161 2544 2548 O
a 162 163 2549 2550 O
negative 164 172 2551 2559 O
family 173 179 2560 2566 O
history 180 187 2567 2574 O
of 188 190 2575 2577 O
HBOC 191 195 2578 2582 B-cancer
syndrome 196 204 2583 2591 I-cancer
, 204 205 2591 2592 O
or 206 208 2593 2595 O
negative 209 217 2596 2604 O
gBRCA1/2 218 226 2605 2613 O
m 226 227 2613 2614 O
test 228 232 2615 2619 O

Patients 0 8 2620 2628 O
enrolling 9 18 2629 2638 O
in 19 21 2639 2641 O
the 22 25 2642 2645 O
sporadic 26 34 2646 2654 O
high 35 39 2655 2659 B-cancer
grade 40 45 2660 2665 I-cancer
serous 46 52 2666 2672 I-cancer
epithelial 53 63 2673 2683 I-cancer
or 64 66 2684 2686 O
high 67 71 2687 2691 B-cancer
grade 72 77 2692 2697 I-cancer
endometrioid 78 90 2698 2710 I-cancer
ovarian 91 98 2711 2718 I-cancer
cancer 99 105 2719 2725 I-cancer
group 106 111 2726 2731 O
, 111 112 2731 2732 O
Cohort 113 119 2733 2739 O
2 120 121 2740 2741 O
, 121 122 2741 2742 O
must 123 127 2743 2747 O
have 128 132 2748 2752 O
a 133 134 2753 2754 O
negative 135 143 2755 2763 O
family 144 150 2764 2770 O
history 151 158 2771 2778 O
of 159 161 2779 2781 O
hereditary 162 172 2782 2792 B-cancer
breast 173 179 2793 2799 I-cancer
ovarian 180 187 2800 2807 I-cancer
cancer 188 194 2808 2814 I-cancer
( 195 196 2815 2816 I-cancer
HBOC 196 200 2816 2820 I-cancer
) 200 201 2820 2821 I-cancer
syndrome 202 210 2822 2830 I-cancer
, 210 211 2830 2831 O
or 212 214 2832 2834 O
negative 215 223 2835 2843 O
gBRCA1/2 224 232 2844 2852 O
m 232 233 2852 2853 O
mutation 234 242 2854 2862 O
test 243 247 2863 2867 O

Patients 0 8 2868 2876 O
enrolling 9 18 2877 2886 O
in 19 21 2887 2889 O
the 22 25 2890 2893 O
triple 26 32 2894 2900 B-cancer
negative 33 41 2901 2909 I-cancer
breast 42 48 2910 2916 I-cancer
cancer 49 55 2917 2923 I-cancer
( 56 57 2924 2925 O
ER-/PR-/Her2- 57 70 2925 2938 B-clinical_variable
) 70 71 2938 2939 O
group 72 77 2940 2945 O
, 77 78 2945 2946 O
Cohort 79 85 2947 2953 O
3 86 87 2954 2955 O
, 87 88 2955 2956 O
must 89 93 2957 2961 O
have 94 98 2962 2966 O
a 99 100 2967 2968 O
negative 101 109 2969 2977 O
family 110 116 2978 2984 O
history 117 124 2985 2992 O
of 125 127 2993 2995 O
HBOC 128 132 2996 3000 B-cancer
syndrome 133 141 3001 3009 O
, 141 142 3009 3010 O
or 143 145 3011 3013 O
negative 146 154 3014 3022 O
gBRCA1/2 155 163 3023 3031 B-treatment
m 163 164 3031 3032 I-treatment
test 165 169 3033 3037 O

Patients 0 8 3038 3046 O
must 9 13 3047 3051 O
be 14 16 3052 3054 O
at 17 19 3055 3057 O
least 20 25 3058 3063 O
1 26 27 3064 3065 B-lower_bound
week 28 32 3066 3070 I-lower_bound
from 33 37 3071 3075 O
the 38 41 3076 3079 O
last 42 46 3080 3084 O
dose 47 51 3085 3089 O
of 52 54 3090 3092 O
complementary 55 68 3093 3106 O
or 69 71 3107 3109 O
alternative 72 83 3110 3121 O
medications 84 95 3122 3133 B-treatment

Patients 0 8 3134 3142 O
must 9 13 3143 3147 O
be 14 16 3148 3150 O
at 17 19 3151 3153 O
least 20 25 3154 3159 O
4 26 27 3160 3161 B-lower_bound
weeks 28 33 3162 3167 I-lower_bound
from 34 38 3168 3172 O
previous 39 47 3173 3181 B-treatment
therapy 48 55 3182 3189 I-treatment
( 56 57 3190 3191 O
chemotherapy 57 69 3191 3203 B-treatment
, 69 70 3203 3204 O
hormonal 71 79 3205 3213 B-treatment
therapy 80 87 3214 3221 I-treatment
, 87 88 3221 3222 O
and 89 92 3223 3226 O
radiation 93 102 3227 3236 B-treatment
therapy 103 110 3237 3244 I-treatment
, 110 111 3244 3245 O
or 112 114 3246 3248 O
investigational 115 130 3249 3264 B-treatment
agents 131 137 3265 3271 I-treatment
; 137 138 3271 3272 O
6 139 140 3273 3274 B-lower_bound
weeks 141 146 3275 3280 I-lower_bound
for 147 150 3281 3284 O
mitomycin 151 160 3285 3294 B-treatment
C 161 162 3295 3296 I-treatment
) 162 163 3296 3297 O

Patients 0 8 3298 3306 O
must 9 13 3307 3311 O
have 14 18 3312 3316 O
normal 19 25 3317 3323 O
organ 26 31 3324 3329 O
and 32 35 3330 3333 O
marrow 36 42 3334 3340 O
function 43 51 3341 3349 O
( 52 53 3350 3351 O
in 53 55 3351 3353 O
the 56 59 3354 3357 O
absence 60 67 3358 3365 O
of 68 70 3366 3368 O
transfusion 71 82 3369 3380 B-treatment
24 83 85 3381 3383 B-upper_bound
hours 86 91 3384 3389 I-upper_bound
prior 92 97 3390 3395 I-upper_bound
to 98 100 3396 3398 O
dosing 101 107 3399 3405 O
) 107 108 3405 3406 O

Patients 0 8 3407 3415 O
should 9 15 3416 3422 O
have 16 20 3423 3427 O
recurrent 21 30 3428 3437 O
platinum 31 39 3438 3446 O
- 39 40 3446 3447 O
resistant 40 49 3447 3456 O
- 50 51 3457 3458 O
defined 52 59 3459 3466 O
as 60 62 3467 3469 O
disease 63 70 3470 3477 O
recurrence 71 81 3478 3488 O
by 82 84 3489 3491 O
imaging 85 92 3492 3499 O
within 93 99 3500 3506 O
6 100 101 3507 3508 B-upper_bound
months 102 108 3509 3515 I-upper_bound
of 109 111 3516 3518 O
the 112 115 3519 3522 O
last 116 120 3523 3527 O
receipt 121 128 3528 3535 O
of 129 131 3536 3538 O
platinum 132 140 3539 3547 B-treatment
- 140 141 3547 3548 I-treatment
based 141 146 3548 3553 I-treatment
chemotherapy 147 159 3554 3566 I-treatment

Patients 0 8 3567 3575 O
should 9 15 3576 3582 O
have 16 20 3583 3587 O
recurrent 21 30 3588 3597 O
platinum 31 39 3598 3606 O
- 39 40 3606 3607 O
resistant 40 49 3607 3616 O
, 49 50 3616 3617 O
defined 51 58 3618 3625 O
as 59 61 3626 3628 O
disease 62 69 3629 3636 O
recurrence 70 80 3637 3647 O
by 81 83 3648 3650 O
imaging 84 91 3651 3658 O
within 92 98 3659 3665 O
6 99 100 3666 3667 B-upper_bound
months 101 107 3668 3674 I-upper_bound
of 108 110 3675 3677 O
the 111 114 3678 3681 O
last 115 119 3682 3686 O
receipt 120 127 3687 3694 O
of 128 130 3695 3697 O
platinum 131 139 3698 3706 O
- 139 140 3706 3707 O
based 140 145 3707 3712 O
chemotherapy 146 158 3713 3725 B-treatment

Patients 0 8 3726 3734 O
who 9 12 3735 3738 O
are 13 16 3739 3742 O
receiving 17 26 3743 3752 O
any 27 30 3753 3756 O
other 31 36 3757 3762 O
investigational 37 52 3763 3778 B-treatment
agents 53 59 3779 3785 I-treatment

Patients 0 8 3786 3794 O
who 9 12 3795 3798 O
have 13 17 3799 3803 O
QTc 18 21 3804 3807 B-clinical_variable
interval 22 30 3808 3816 I-clinical_variable
of 31 33 3817 3819 O
> 34 35 3820 3821 O
470 36 39 3822 3825 B-lower_bound
msec 40 44 3826 3830 I-lower_bound
on 45 47 3831 3833 O
a 48 49 3834 3835 O
screening 50 59 3836 3845 O
electrocardiogram 60 77 3846 3863 O

Patients 0 8 3864 3872 O
who 9 12 3873 3876 O
have 13 17 3877 3881 O
had 18 21 3882 3885 O
major 22 27 3886 3891 B-treatment
surgery 28 35 3892 3899 I-treatment
must 36 40 3900 3904 O
be 41 43 3905 3907 O
fully 44 49 3908 3913 O
recovered 50 59 3914 3923 O
and 60 63 3924 3927 O
greater 64 71 3928 3935 O
than 72 76 3936 3940 O
or 77 79 3941 3943 O
equal 80 85 3944 3949 O
to 86 88 3950 3952 O
4 89 90 3953 3954 B-lower_bound
weeks 91 96 3955 3960 I-lower_bound
postoperative 97 110 3961 3974 O
prior 111 116 3975 3980 O
to 117 119 3981 3983 O
enrolling 120 129 3984 3993 O
on 130 132 3994 3996 O
study 133 138 3997 4002 O

Patients 0 8 4003 4011 O
who 9 12 4012 4015 O
have 13 17 4016 4020 O
had 18 21 4021 4024 O
prior 22 27 4025 4030 B-treatment
treatment 28 37 4031 4040 I-treatment
with 38 42 4041 4045 I-treatment
LY2606368 43 52 4046 4055 I-treatment
or 53 55 4056 4058 I-treatment
other 56 61 4059 4064 I-treatment
Chk 62 65 4065 4068 I-treatment
inhibitors 66 76 4069 4079 I-treatment

Patients 0 8 4080 4088 O
with 9 13 4089 4093 O
VUS 14 17 4094 4097 O
or 18 20 4098 4100 O
deleterious 21 32 4101 4112 O
mutation 33 41 4113 4121 O
in 42 44 4122 4124 O
other 45 50 4125 4130 O
genes 51 56 4131 4136 O
without 57 64 4137 4144 O
gBRCA1/2 65 73 4145 4153 O
m 73 74 4153 4154 O
can 75 78 4155 4158 O
be 79 81 4159 4161 O
considered 82 92 4162 4172 O
for 93 96 4173 4176 O
Cohort 97 103 4177 4183 B-clinical_variable
2 104 105 4184 4185 O
or 106 108 4186 4188 O
3 109 110 4189 4190 O
or 111 113 4191 4193 O
5 114 115 4194 4195 B-upper_bound

Patients 0 8 4196 4204 O
with 9 13 4205 4209 O
a 14 15 4210 4211 O
prior 16 21 4212 4217 O
history 22 29 4218 4225 O
of 30 32 4226 4228 O
drug 33 37 4229 4233 O
- 37 38 4233 4234 O
induced 38 45 4234 4241 O
serotonin 46 55 4242 4251 B-chronic_disease
syndrome 56 64 4252 4260 I-chronic_disease
, 64 65 4260 4261 O
or 66 68 4262 4264 O
a 69 70 4265 4266 O
family 71 77 4267 4273 O
history 78 85 4274 4281 O
of 86 88 4282 4284 O
long 89 93 4285 4289 B-chronic_disease
- 93 94 4289 4290 I-chronic_disease
QT 94 96 4290 4292 I-chronic_disease
syndrome 97 105 4293 4301 I-chronic_disease

Patients 0 8 4302 4310 O
with 9 13 4311 4315 O
a 14 15 4316 4317 O
serious 16 23 4318 4325 B-chronic_disease
cardiac 24 31 4326 4333 I-chronic_disease
condition 32 41 4334 4343 I-chronic_disease
, 41 42 4343 4344 O
such 43 47 4345 4349 O
as 48 50 4350 4352 O
congestive 51 61 4353 4363 B-chronic_disease
heart 62 67 4364 4369 I-chronic_disease
failure 68 75 4370 4377 I-chronic_disease
; 75 76 4377 4378 O
New 77 80 4379 4382 O
York 81 85 4383 4387 O
Heart 86 91 4388 4393 O
Association 92 103 4394 4405 O
Class 104 109 4406 4411 O
III 110 113 4412 4415 B-lower_bound
/ 113 114 4415 4416 O
IV 114 116 4416 4418 B-upper_bound
heart 117 122 4419 4424 B-chronic_disease
disease 123 130 4425 4432 I-chronic_disease
; 130 131 4432 4433 O
unstable 132 140 4434 4442 B-chronic_disease
angina 141 147 4443 4449 I-chronic_disease
pectoris 148 156 4450 4458 I-chronic_disease

Patients 0 8 4459 4467 O
with 9 13 4468 4472 O
brain 14 19 4473 4478 B-cancer
metastases 20 30 4479 4489 I-cancer
diagnosed 31 40 4490 4499 O
greater 41 48 4500 4507 O
than 49 53 4508 4512 O
1 54 55 4513 4514 B-lower_bound
year 56 60 4515 4519 I-lower_bound
prior 61 66 4520 4525 I-lower_bound
to 67 69 4526 4528 O
study 70 75 4529 4534 O
entry 76 81 4535 4540 O
may 82 85 4541 4544 O
be 86 88 4545 4547 O
considered 89 99 4548 4558 O
if 100 102 4559 4561 O
they 103 107 4562 4566 O
received 108 116 4567 4575 O
sterilizing 117 128 4576 4587 B-treatment
therapy 129 136 4588 4595 I-treatment
to 137 139 4596 4598 O
the 140 143 4599 4602 O
CNS 144 147 4603 4606 O
( 148 149 4607 4608 O
resection 149 158 4608 4617 B-treatment
or 159 161 4618 4620 O
radiation 162 171 4621 4630 B-treatment
) 171 172 4630 4631 O
and 173 176 4632 4635 O
have 177 181 4636 4640 O
been 182 186 4641 4645 O
CNS 187 190 4646 4649 O
recurrence 191 201 4650 4660 O
- 201 202 4660 4661 O
free 202 206 4661 4665 O
for 207 210 4666 4669 O
the 211 214 4670 4673 O
1 215 216 4674 4675 B-upper_bound
- 216 217 4675 4676 I-upper_bound
year 217 221 4676 4680 I-upper_bound
period 222 228 4681 4687 I-upper_bound

Patients 0 8 4688 4696 O
with 9 13 4697 4701 O
gBRCA1/2 14 22 4702 4710 O
m 22 23 4710 4711 O
and 24 27 4712 4715 O
primary 28 35 4716 4723 O
breast 36 42 4724 4730 B-cancer
or 43 45 4731 4733 O
ovarian 46 53 4734 4741 B-cancer
cancers 54 61 4742 4749 I-cancer
will 62 66 4750 4754 O
be 67 69 4755 4757 O
eligible 70 78 4758 4766 O
for 79 82 4767 4770 O
Cohort 83 89 4771 4777 O
1 90 91 4778 4779 O

Patients 0 8 4780 4788 O
with 9 13 4789 4793 O
gBRCA1/2 14 22 4794 4802 B-clinical_variable
m 22 23 4802 4803 I-clinical_variable
with 24 28 4804 4808 O
history 29 36 4809 4816 O
of 37 39 4817 4819 O
or 40 42 4820 4822 O
active 43 49 4823 4829 O
breast 50 56 4830 4836 B-cancer
and 57 60 4837 4840 I-cancer
ovarian 61 68 4841 4848 I-cancer
cancers 69 76 4849 4856 I-cancer
are 77 80 4857 4860 O
considered 81 91 4861 4871 O
for 92 95 4872 4875 O
Cohort 96 102 4876 4882 O
1 103 104 4883 4884 O

Patients 0 8 4885 4893 O
with 9 13 4894 4898 O
known 14 19 4899 4904 O
brain 20 25 4905 4910 B-cancer
metastases 26 36 4911 4921 I-cancer
should 37 43 4922 4928 O
be 44 46 4929 4931 O
excluded 47 55 4932 4940 O
from 56 60 4941 4945 O
this 61 65 4946 4950 O
clinical 66 74 4951 4959 O
trial 75 80 4960 4965 O
because 81 88 4966 4973 O
of 89 91 4974 4976 O
their 92 97 4977 4982 O
poor 98 102 4983 4987 O
prognosis 103 112 4988 4997 O
and 113 116 4998 5001 O
because 117 124 5002 5009 O
they 125 129 5010 5014 O
often 130 135 5015 5020 O
develop 136 143 5021 5028 O
progressive 144 155 5029 5040 B-chronic_disease
neurologic 156 166 5041 5051 I-chronic_disease
dysfunction 167 178 5052 5063 I-chronic_disease
that 179 183 5064 5068 O
would 184 189 5069 5074 O
confound 190 198 5075 5083 O
the 199 202 5084 5087 O
evaluation 203 213 5088 5098 O
of 214 216 5099 5101 O
neurologic 217 227 5102 5112 O
and 228 231 5113 5116 O
other 232 237 5117 5122 O
adverse 238 245 5123 5130 O
events 246 252 5131 5137 O

Patients 0 8 5138 5146 O
with 9 13 5147 5151 O
platinum 14 22 5152 5160 O
- 22 23 5160 5161 O
related 23 30 5161 5168 O
grade 31 36 5169 5174 B-lower_bound
2 37 38 5175 5176 I-lower_bound
or 39 41 5177 5179 O
greater 42 49 5180 5187 O
hypomagnesemia 50 64 5188 5202 B-clinical_variable
( 65 66 5203 5204 O
on 66 68 5204 5206 O
replacement 69 80 5207 5218 O
) 80 81 5218 5219 O

Patients 0 8 5220 5228 O
with 9 13 5229 5233 O
primary 14 21 5234 5241 O
platinum 22 30 5242 5250 B-cancer
refractory 31 41 5251 5261 I-cancer
disease 42 49 5262 5269 I-cancer
defined 50 57 5270 5277 O
as 58 60 5278 5280 O
progression 61 72 5281 5292 O
during 73 79 5293 5299 O
or 80 82 5300 5302 O
within 83 89 5303 5309 O
3 90 91 5310 5311 B-upper_bound
months 92 98 5312 5318 I-upper_bound
after 99 104 5319 5324 I-upper_bound
receiving 105 114 5325 5334 O
first 115 120 5335 5340 O
- 120 121 5340 5341 O
line 121 125 5341 5345 O
platinum 126 134 5346 5354 B-treatment
based 135 140 5355 5360 I-treatment
chemotherapy 141 153 5361 5373 I-treatment

Potassium 0 9 5374 5383 B-clinical_variable
( 10 11 5384 5385 I-clinical_variable
K 11 12 5385 5386 I-clinical_variable
) 12 13 5386 5387 I-clinical_variable
should 14 20 5388 5394 O
be 21 23 5395 5397 O
within 24 30 5398 5404 O
the 31 34 5405 5408 O
range 35 40 5409 5414 O
of 41 43 5415 5417 O
greater 44 51 5418 5425 O
than 52 56 5426 5430 O
or 57 59 5431 5433 O
equal 60 65 5434 5439 O
to 66 68 5440 5442 O
3.6 69 72 5443 5446 B-lower_bound
mEq 73 76 5447 5450 I-lower_bound
/ 76 77 5450 5451 I-lower_bound
L 77 78 5451 5452 I-lower_bound

Should 0 6 5453 5459 O
a 7 8 5460 5461 O
woman 9 14 5462 5467 B-gender
become 15 21 5468 5474 O
pregnant 22 30 5475 5483 B-pregnancy
or 31 33 5484 5486 O
suspect 34 41 5487 5494 O
she 42 45 5495 5498 O
is 46 48 5499 5501 O
pregnant 49 57 5502 5510 O
while 58 63 5511 5516 O
she 64 67 5517 5520 O
is 68 70 5521 5523 O
participating 71 84 5524 5537 O
in 85 87 5538 5540 O
this 88 92 5541 5545 O
study 93 98 5546 5551 O
, 98 99 5551 5552 O
she 100 103 5553 5556 O
should 104 110 5557 5563 O
inform 111 117 5564 5570 O
her 118 121 5571 5574 O
treating 122 130 5575 5583 O
physician 131 140 5584 5593 O
immediately 141 152 5594 5605 O

Stable 0 6 5606 5612 O
persistent 7 17 5613 5623 O
grade 18 23 5624 5629 B-chronic_disease
2 24 25 5630 5631 I-chronic_disease
peripheral 26 36 5632 5642 I-chronic_disease
neuropathy 37 47 5643 5653 I-chronic_disease
may 48 51 5654 5657 O
be 52 54 5658 5660 O
allowed 55 62 5661 5668 O
as 63 65 5669 5671 O
determined 66 76 5672 5682 O
on 77 79 5683 5685 O
a 80 81 5686 5687 O
case 82 86 5688 5692 O
- 86 87 5692 5693 O
by 87 89 5693 5695 O
- 89 90 5695 5696 O
case 90 94 5696 5700 O
basis 95 100 5701 5706 O
at 101 103 5707 5709 O
the 104 107 5710 5713 O
discretion 108 118 5714 5724 O
of 119 121 5725 5727 O
the 122 125 5728 5731 O
PI 126 128 5732 5734 O

The 0 3 5735 5738 O
use 4 7 5739 5742 O
of 8 10 5743 5745 O
raloxifene 11 21 5746 5756 B-treatment
, 21 22 5756 5757 O
denosumab 23 32 5758 5767 B-treatment
, 32 33 5767 5768 O
or 34 36 5769 5771 O
bisphosphonates 37 52 5772 5787 B-treatment
for 53 56 5788 5791 O
bone 57 61 5792 5796 O
health 62 68 5797 5803 O

There 0 5 5804 5809 O
is 6 8 5810 5812 O
no 9 11 5813 5815 O
limit 12 17 5816 5821 O
on 18 20 5822 5824 O
the 21 24 5825 5828 O
number 25 31 5829 5835 O
of 32 34 5836 5838 O
prior 35 40 5839 5844 B-treatment
therapies 41 50 5845 5854 I-treatment

Uncontrolled 0 12 5855 5867 O
intercurrent 13 25 5868 5880 B-chronic_disease
illness 26 33 5881 5888 I-chronic_disease
including 34 43 5889 5898 O
, 43 44 5898 5899 O
but 45 48 5900 5903 O
not 49 52 5904 5907 O
limited 53 60 5908 5915 O
to 61 63 5916 5918 O
, 63 64 5918 5919 O
symptomatic 65 76 5920 5931 O
congestive 77 87 5932 5942 B-chronic_disease
heart 88 93 5943 5948 I-chronic_disease
failure 94 101 5949 5956 I-chronic_disease
, 101 102 5956 5957 O
unstable 103 111 5958 5966 O
angina 112 118 5967 5973 B-chronic_disease
pectoris 119 127 5974 5982 I-chronic_disease
, 127 128 5982 5983 O
cardiac 129 136 5984 5991 O
arrhythmia 137 147 5992 6002 B-chronic_disease
, 147 148 6002 6003 O
clinically 149 159 6004 6014 O
significant 160 171 6015 6026 O
GI 172 174 6027 6029 B-chronic_disease
bleeding 175 183 6030 6038 I-chronic_disease
or 184 186 6039 6041 O
hemoptysis 187 197 6042 6052 B-chronic_disease
within 198 204 6053 6059 O
28 205 207 6060 6062 B-upper_bound
days 208 212 6063 6067 I-upper_bound
prior 213 218 6068 6073 I-upper_bound
to 219 221 6074 6076 O
the 222 225 6077 6080 O
start 226 231 6081 6086 O
of 232 234 6087 6089 O
the 235 238 6090 6093 O
study 239 244 6094 6099 O
, 244 245 6099 6100 O
or 246 248 6101 6103 O
psychiatric 249 260 6104 6115 B-chronic_disease
illness 261 268 6116 6123 I-chronic_disease
/ 268 269 6123 6124 O
social 269 275 6124 6130 O
situations 276 286 6131 6141 O
that 287 291 6142 6146 O
would 292 297 6147 6152 O
limit 298 303 6153 6158 O
compliance 304 314 6159 6169 O
with 315 319 6170 6174 O
study 320 325 6175 6180 O
requirements 326 338 6181 6193 O

Women 0 5 6194 6199 B-gender
of 6 8 6200 6202 O
childbearing 9 21 6203 6215 O
potential 22 31 6216 6225 O
must 32 36 6226 6230 O
have 37 41 6231 6235 O
a 42 43 6236 6237 O
negative 44 52 6238 6246 B-pregnancy
urine 53 58 6247 6252 I-pregnancy
or 59 61 6253 6255 I-pregnancy
serum 62 67 6256 6261 I-pregnancy
pregnancy 68 77 6262 6271 I-pregnancy
test 78 82 6272 6276 O
within 83 89 6277 6283 O
7 90 91 6284 6285 B-upper_bound
days 92 96 6286 6290 I-upper_bound
prior 97 102 6291 6296 I-upper_bound
to 103 105 6297 6299 O
the 106 109 6300 6303 O
start 110 115 6304 6309 O
of 116 118 6310 6312 O
the 119 122 6313 6316 O
study 123 128 6317 6322 O

absolute 0 8 6323 6331 B-clinical_variable
neutrophil 9 19 6332 6342 I-clinical_variable
count 20 25 6343 6348 I-clinical_variable
greater 26 33 6349 6356 O
than 34 38 6357 6361 O
or 39 41 6362 6364 O
equal 42 47 6365 6370 O
to 48 50 6371 6373 O
1,500 51 56 6374 6379 B-lower_bound
/ 56 57 6379 6380 I-lower_bound
mcL 57 60 6380 6383 I-lower_bound

all 0 3 6384 6387 O
subjects 4 12 6388 6396 O
of 13 15 6397 6399 O
reproductive 16 28 6400 6412 O
potential 29 38 6413 6422 O
must 39 43 6423 6427 O
agree 44 49 6428 6433 B-contraception_consent
to 50 52 6434 6436 I-contraception_consent
use 53 56 6437 6440 I-contraception_consent
adequate 57 65 6441 6449 I-contraception_consent
contraception 66 79 6450 6463 I-contraception_consent
prior 80 85 6464 6469 O
to 86 88 6470 6472 O
study 89 94 6473 6478 O
entry 95 100 6479 6484 O
, 100 101 6484 6485 O
for 102 105 6486 6489 O
the 106 109 6490 6493 O
duration 110 118 6494 6502 O
of 119 121 6503 6505 O
study 122 127 6506 6511 O
participation 128 141 6512 6525 O
, 141 142 6525 6526 O
and 143 146 6527 6530 O
for 147 150 6531 6534 O
at 151 153 6535 6537 O
least 154 159 6538 6543 O
four 160 164 6544 6548 B-lower_bound
months 165 171 6549 6555 I-lower_bound
following 172 181 6556 6565 O
the 182 185 6566 6569 O
last 186 190 6570 6574 O
dose 191 195 6575 6579 O
of 196 198 6580 6582 O
experimental 199 211 6583 6595 B-treatment
therapy 212 219 6596 6603 I-treatment

creatinine 0 10 6604 6614 B-clinical_variable
less 11 15 6615 6619 O
than 16 20 6620 6624 O
or 21 23 6625 6627 O
equal 24 29 6628 6633 O
to 30 32 6634 6636 O
1.5 33 36 6637 6640 B-upper_bound
X 37 38 6641 6642 I-upper_bound
institutional 39 52 6643 6656 I-upper_bound
upper 53 58 6657 6662 I-upper_bound
limit 59 64 6663 6668 I-upper_bound
of 65 67 6669 6671 I-upper_bound
normal 68 74 6672 6678 I-upper_bound

hemoglobin 0 10 6679 6689 B-clinical_variable
greater 11 18 6690 6697 O
than 19 23 6698 6702 O
or 24 26 6703 6705 O
equal 27 32 6706 6711 O
to 33 35 6712 6714 O
10mg 36 40 6715 6719 B-lower_bound
/ 40 41 6719 6720 I-lower_bound
dL 41 43 6720 6722 I-lower_bound

leukocytes 0 10 6723 6733 B-clinical_variable
greater 11 18 6734 6741 O
than 19 23 6742 6746 O
or 24 26 6747 6749 O
equal 27 32 6750 6755 O
to 33 35 6756 6758 O
3,000 36 41 6759 6764 B-lower_bound
/ 41 42 6764 6765 I-lower_bound
mcL 42 45 6765 6768 I-lower_bound

myocardial 0 10 6769 6779 B-chronic_disease
infarction 11 21 6780 6790 I-chronic_disease
within 22 28 6791 6797 O
the 29 32 6798 6801 O
last 33 37 6802 6806 B-upper_bound
3 38 39 6807 6808 I-upper_bound
months 40 46 6809 6815 I-upper_bound

platelets 0 9 6816 6825 B-clinical_variable
greater 10 17 6826 6833 O
than 18 22 6834 6838 O
or 23 25 6839 6841 O
equal 26 31 6842 6847 O
to 32 34 6848 6850 O
100,000 35 42 6851 6858 B-lower_bound
/ 42 43 6858 6859 I-lower_bound
mcL 43 46 6859 6862 I-lower_bound

total 0 5 6863 6868 B-clinical_variable
bilirubin 6 15 6869 6878 I-clinical_variable
less 16 20 6879 6883 O
than 21 25 6884 6888 O
or 26 28 6889 6891 O
equal 29 34 6892 6897 O
to 35 37 6898 6900 O
1.5 38 41 6901 6904 B-upper_bound
X 42 43 6905 6906 I-upper_bound
institutional 44 57 6907 6920 I-upper_bound
upper 58 63 6921 6926 I-upper_bound
limit 64 69 6927 6932 I-upper_bound
of 70 72 6933 6935 I-upper_bound
normal 73 79 6936 6942 I-upper_bound

valvulopathy 0 12 6943 6955 B-chronic_disease
that 13 17 6956 6960 O
is 18 20 6961 6963 O
severe 21 27 6964 6970 O
, 27 28 6970 6971 O
moderate 29 37 6972 6980 O
, 37 38 6980 6981 O
or 39 41 6982 6984 O
deemed 42 48 6985 6991 O
clinically 49 59 6992 7002 O
significant 60 71 7003 7014 O
despite 72 79 7015 7022 O
medical 80 87 7023 7030 B-treatment
intervention 88 100 7031 7043 I-treatment
; 100 101 7043 7044 O
or 102 104 7045 7047 O
arrhythmias 105 116 7048 7059 B-chronic_disease
that 117 121 7060 7064 O
are 122 125 7065 7068 O
symptomatic 126 137 7069 7080 O
or 138 140 7081 7083 O
refractory 141 151 7084 7094 O
to 152 154 7095 7097 O
medical 155 162 7098 7105 O
intervention 163 175 7106 7118 O

